IHT Wealth Management, LLC - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 68 filers reported holding CASI PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
IHT Wealth Management, LLC ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$65,000
+32.7%
26,000
+8.3%
0.01%
+28.6%
Q1 2020$49,000
-47.3%
24,000
-20.0%
0.01%
-36.4%
Q4 2019$93,000
-7.0%
30,0000.0%0.01%
-21.4%
Q3 2019$100,000
+4.2%
30,0000.0%0.01%0.0%
Q2 2019$96,000
+17.1%
30,000
+4.4%
0.01%0.0%
Q1 2019$82,000
-13.7%
28,725
+21.1%
0.01%
-22.2%
Q4 2018$95,000
+90.0%
23,725
+121.2%
0.02%
+63.6%
Q3 2018$50,000
+66.7%
10,725
+53.2%
0.01%
+37.5%
Q1 2018$30,000
+20.0%
7,0000.0%0.01%
+14.3%
Q4 2017$25,0007,0000.01%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Wellington Shields Capital Management, LLC 2,188,547$1,751,0000.22%
Wellington Shields & Co., LLC 1,141,190$913,0000.18%
Ikarian Capital, LLC 1,223,067$978,0000.15%
Ground Swell Capital, LLC 18,638$15,0000.09%
Anson Funds Management LP 267,507$214,0000.02%
Sterneck Capital Management, LLC 40,000$32,0000.02%
FEDERATED HERMES, INC. 10,150,000$8,120,0000.02%
Roundview Capital LLC 122,453$98,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,677,146$1,342,0000.01%
RBF Capital, LLC 159,367$127,0000.01%
View complete list of CASI PHARMACEUTICALS INC shareholders